vs

Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and RAYONIER ADVANCED MATERIALS INC. (RYAM). Click either name above to swap in a different company.

American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $417.5M, roughly 1.4× RAYONIER ADVANCED MATERIALS INC.). American Healthcare REIT, Inc. runs the higher net margin — 1.9% vs -5.0%, a 7.0% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs -1.2%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs 3.8%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Rayonier Advanced Materials recently rebranded as RYAM. RYAM is an American company recognized globally for its cellulose-based technologies. Specializing in high-purity cellulose specialties, RYAM produces natural polymers extensively used in manufacturing filters, food, pharmaceuticals, and various industrial applications. Additionally, the company produces products for the paper and packaging industries. The company is publicly traded on the New York Stock Exchange under the ticker symbol ...

AHR vs RYAM — Head-to-Head

Bigger by revenue
AHR
AHR
1.4× larger
AHR
$564.0M
$417.5M
RYAM
Growing faster (revenue YoY)
AHR
AHR
+14.7% gap
AHR
13.5%
-1.2%
RYAM
Higher net margin
AHR
AHR
7.0% more per $
AHR
1.9%
-5.0%
RYAM
Faster 2-yr revenue CAGR
AHR
AHR
Annualised
AHR
11.7%
3.8%
RYAM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AHR
AHR
RYAM
RYAM
Revenue
$564.0M
$417.5M
Net Profit
$10.8M
$-21.1M
Gross Margin
14.8%
8.9%
Operating Margin
19.8%
2.6%
Net Margin
1.9%
-5.0%
Revenue YoY
13.5%
-1.2%
Net Profit YoY
133.9%
-31.9%
EPS (diluted)
$0.07
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHR
AHR
RYAM
RYAM
Q4 25
$564.0M
$417.5M
Q3 25
$532.1M
$352.8M
Q2 25
$501.3M
$340.0M
Q1 25
$497.2M
$356.0M
Q4 24
$496.8M
$422.5M
Q3 24
$476.8M
$401.1M
Q2 24
$458.0M
$419.0M
Q1 24
$452.1M
$387.7M
Net Profit
AHR
AHR
RYAM
RYAM
Q4 25
$10.8M
$-21.1M
Q3 25
$55.9M
$-4.5M
Q2 25
$9.9M
$-363.2M
Q1 25
$-6.8M
$-32.0M
Q4 24
$-31.8M
$-16.0M
Q3 24
$-4.1M
$-32.6M
Q2 24
$2.0M
$11.4M
Q1 24
$-3.9M
$-1.6M
Gross Margin
AHR
AHR
RYAM
RYAM
Q4 25
14.8%
8.9%
Q3 25
14.6%
9.7%
Q2 25
15.0%
7.0%
Q1 25
13.0%
6.8%
Q4 24
13.3%
8.7%
Q3 24
12.5%
10.9%
Q2 24
12.1%
11.5%
Q1 24
10.7%
9.5%
Operating Margin
AHR
AHR
RYAM
RYAM
Q4 25
19.8%
2.6%
Q3 25
19.9%
2.8%
Q2 25
20.6%
-0.4%
Q1 25
19.0%
-4.2%
Q4 24
20.0%
2.6%
Q3 24
19.6%
-4.2%
Q2 24
19.4%
6.7%
Q1 24
18.2%
4.4%
Net Margin
AHR
AHR
RYAM
RYAM
Q4 25
1.9%
-5.0%
Q3 25
10.5%
-1.3%
Q2 25
2.0%
-106.8%
Q1 25
-1.4%
-9.0%
Q4 24
-6.4%
-3.8%
Q3 24
-0.9%
-8.1%
Q2 24
0.4%
2.7%
Q1 24
-0.9%
-0.4%
EPS (diluted)
AHR
AHR
RYAM
RYAM
Q4 25
$0.07
$-0.33
Q3 25
$0.33
$-0.07
Q2 25
$0.06
$-5.44
Q1 25
$-0.04
$-0.49
Q4 24
$-0.23
$-0.25
Q3 24
$-0.03
$-0.49
Q2 24
$0.01
$0.17
Q1 24
$-0.04
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHR
AHR
RYAM
RYAM
Cash + ST InvestmentsLiquidity on hand
$114.8M
$75.4M
Total DebtLower is stronger
$758.1M
Stockholders' EquityBook value
$3.3B
$316.6M
Total Assets
$5.4B
$1.8B
Debt / EquityLower = less leverage
2.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHR
AHR
RYAM
RYAM
Q4 25
$114.8M
$75.4M
Q3 25
$147.4M
$77.0M
Q2 25
$133.5M
$70.7M
Q1 25
$86.1M
$129.9M
Q4 24
$76.7M
$125.2M
Q3 24
$67.8M
$136.1M
Q2 24
$52.1M
$114.1M
Q1 24
$77.0M
$54.6M
Total Debt
AHR
AHR
RYAM
RYAM
Q4 25
$758.1M
Q3 25
$763.5M
Q2 25
$720.4M
Q1 25
$707.0M
Q4 24
$706.4M
Q3 24
$747.7M
Q2 24
$752.8M
Q1 24
$755.6M
Stockholders' Equity
AHR
AHR
RYAM
RYAM
Q4 25
$3.3B
$316.6M
Q3 25
$2.7B
$338.2M
Q2 25
$2.4B
$342.3M
Q1 25
$2.3B
$688.1M
Q4 24
$2.3B
$713.9M
Q3 24
$2.2B
$732.7M
Q2 24
$1.9B
$755.1M
Q1 24
$2.0B
$741.8M
Total Assets
AHR
AHR
RYAM
RYAM
Q4 25
$5.4B
$1.8B
Q3 25
$4.8B
$1.8B
Q2 25
$4.5B
$1.8B
Q1 25
$4.5B
$2.1B
Q4 24
$4.5B
$2.1B
Q3 24
$4.7B
$2.2B
Q2 24
$4.6B
$2.2B
Q1 24
$4.7B
$2.1B
Debt / Equity
AHR
AHR
RYAM
RYAM
Q4 25
2.39×
Q3 25
2.26×
Q2 25
2.10×
Q1 25
1.03×
Q4 24
0.99×
Q3 24
1.02×
Q2 24
1.00×
Q1 24
1.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHR
AHR
RYAM
RYAM
Operating Cash FlowLast quarter
$55.2M
$32.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
5.12×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHR
AHR
RYAM
RYAM
Q4 25
$55.2M
$32.3M
Q3 25
$107.2M
$-17.8M
Q2 25
$71.5M
$-30.2M
Q1 25
$60.6M
$39.6M
Q4 24
$59.5M
$54.9M
Q3 24
$63.1M
$49.8M
Q2 24
$59.4M
$87.6M
Q1 24
$-6.0M
$11.3M
Cash Conversion
AHR
AHR
RYAM
RYAM
Q4 25
5.12×
Q3 25
1.92×
Q2 25
7.21×
Q1 25
Q4 24
Q3 24
Q2 24
30.02×
7.69×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHR
AHR

Integrated Senior Health Campuses$467.0M83%
SHOP$97.0M17%

RYAM
RYAM

Cellulose Specialties$249.6M60%
Other$86.2M21%
Paperboard$44.2M11%
High Yield Pulp$28.3M7%
Biomaterials$9.2M2%

Related Comparisons